eIF4E was upregulated in breast cancer, colon cancer, head and neck cancer, non-Hodgkin’s lymphoma, and ovarian carcinoma, and was associated with the increasing grade of a disease [26,27]. Here, EIF4E is linked to ovarian carcinoma.